Related Experiment Video
Updated: Jun 24, 2026

07:48
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Targeting stromal-cancer cell interactions with siRNAs
Seyedhossein Aharinejad1, Mouldy Sioud, Trevor Lucas
1Laboratory for Cardiovascular Research, Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria.
Methods in Molecular Biology (Clifton, N.J.)
|March 24, 2009
Summary
Targeting tumor-stroma interactions offers a promising strategy for novel cancer treatments. Understanding the tumor microenvironment and its cellular components is key to developing effective therapies.
Area of Science:
- Oncology
- Cancer Biology
- Cellular Interactions
Background:
- Tumors comprise malignant cells and diverse stromal cells like fibroblasts, endothelial cells, and macrophages.
- Tumor and stromal cells engage in complex interactions that drive cancer progression and metastasis.
Purpose of the Study:
- To summarize the current understanding of the tumor microenvironment.
- To highlight potential therapeutic targets within tumor-stroma interactions for cancer treatment.
Main Methods:
- Review of existing literature on tumor microenvironment and cancer cell-stroma interactions.
- Identification of key molecular players and signaling pathways involved in these interactions.
Main Results:
- Stromal cells, particularly macrophages, contribute to tumor growth and metastasis through secreted factors like colony-stimulating factor-1 (CSF-1) and vascular endothelial growth factor.
- Growth factors and cytokines from the stroma activate oncogenic signaling pathways, promoting tumor cell proliferation.
- Matrix metalloproteinases (MMPs) from tumor and stromal compartments facilitate tumor cell metastasis.
Conclusions:
- Targeting tumor-stroma interactions represents a promising therapeutic strategy for human cancers.
- Further research into the tumor microenvironment can identify novel targets for intervention, including small interfering RNAs (siRNAs).
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

